ATE53235T1 - Synthese von menschlichen viralen antigenen mit hilfe von hefe. - Google Patents

Synthese von menschlichen viralen antigenen mit hilfe von hefe.

Info

Publication number
ATE53235T1
ATE53235T1 AT82401473T AT82401473T ATE53235T1 AT E53235 T1 ATE53235 T1 AT E53235T1 AT 82401473 T AT82401473 T AT 82401473T AT 82401473 T AT82401473 T AT 82401473T AT E53235 T1 ATE53235 T1 AT E53235T1
Authority
AT
Austria
Prior art keywords
yeast
hbsag
synthesis
purified
particles
Prior art date
Application number
AT82401473T
Other languages
English (en)
Inventor
William J Rutter
Pablo D T Valenzuela
Benjamin D Hall
Gustav Ammerer
Original Assignee
Univ California
Washington Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Washington Res Found filed Critical Univ California
Priority claimed from EP82401473A external-priority patent/EP0072318B1/de
Application granted granted Critical
Publication of ATE53235T1 publication Critical patent/ATE53235T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT82401473T 1981-08-04 1982-08-04 Synthese von menschlichen viralen antigenen mit hilfe von hefe. ATE53235T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28991581A 1981-08-04 1981-08-04
EP82401473A EP0072318B1 (de) 1981-08-04 1982-08-04 Synthese von menschlichen viralen Antigenen mit Hilfe von Hefe

Publications (1)

Publication Number Publication Date
ATE53235T1 true ATE53235T1 (de) 1990-06-15

Family

ID=26086453

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82401473T ATE53235T1 (de) 1981-08-04 1982-08-04 Synthese von menschlichen viralen antigenen mit hilfe von hefe.

Country Status (2)

Country Link
EP (1) EP0340806B1 (de)
AT (1) ATE53235T1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE53176B1 (en) * 1978-12-22 1988-08-17 Biogen Nv Recombinant dna molecules and their method of production
IE52036B1 (en) * 1979-05-24 1987-05-27 Univ California Non-passageable viruses
DE3176404D1 (en) * 1980-04-22 1987-10-08 Pasteur Institut Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast

Also Published As

Publication number Publication date
EP0340806A2 (de) 1989-11-08
EP0340806A3 (en) 1989-12-20
EP0340806B1 (de) 1995-05-31

Similar Documents

Publication Publication Date Title
DE3280186D1 (de) Synthese von menschlichen viralen antigenen mit hilfe von hefe.
IL95153A0 (en) Novel antigens and their production
EP0291586A3 (de) Rekombinantes Hepatitis-B-Oberflächenantigen und dieses enthaltender Impfstoff
ATE59409T1 (de) Herstellung von oberflaechen-hepatitis-b-antigen in hefe.
PL279426A1 (en) Method of intensifying generation of antigenic hbv particles containing essentially s and pre s2 proteins
KR920007683B1 (ko) HBs항원의 정제방법
ATE91718T1 (de) Rekombinante dns-molekuele die hepatitis-boberfl|chenantigenkodieren, deren herstellung und abgeleitete vakzine.
ATE53235T1 (de) Synthese von menschlichen viralen antigenen mit hilfe von hefe.
EP0105141A3 (de) Rekombinante DNS Moleküle, Verfahren zu deren Herstellung, deren Verwendung zur Herstellung von Hepatitis B Oberflächen-Antigen (HBsAg) und pharmazeutische Zusammensetzungen die das HBsAg enthalten
EP0248410A3 (de) Hefe-Promotor und Verfahren zur Herstellung von heterologen Proteinen
DE3750330D1 (de) Verfahren zur Herstellung eines Impfstoffs gegen Hepatitis B.
Stephenne Production in yeast and mammalian cells of the first recombinant DNA human vaccine against hepatitis B: A technical and immunological comparison.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time